Dude, you need to read what I actually said. I never said any of this. You keep arguing with me like I'm an anti-vaxxer, when I'm not.
That's how it works, yes. But that's cell per spike protein produced. Did you not understand that? The question is ... how long does the body continue to produce the spike proteins? How long before it 'forgets' the mRNA needed? I mean ...
Did you miss the whole reason why we've been discussing booster v. no booster, duration and other things? Pfizer, Moderna, et al. are also trying to develop tests to figure out when someone needs a booster. Why?
How long does it take the body before it removes most of the spike proteins and forgets how to produce them, or at least enough of them? It's never fully removed, but it does reach a point where its ineffective.
Is it 6 months? A year? 2 years? And how do we test if it's 'sticking around'?
A complicating factor here is that vaccines are low-margins, which is why no one in Big Pharma wanted to touch a SARS-CoV-2 vaccines. That's why the first attempts were with mRNA, because it's cake and cheap to produce, compared to other vaccines.
And with the US FDA granting blanket immunity, 0 fiscal liability meant they would move forward with mRNA.
Everyone needs to stop thinking this is a 'proven delivery mechanism.' It's a new, cheap'n easy one. Vaccines are low-margin, and most have gotten out of the business. mRNA may change that long-term. But we just don't know.
It could be the greatest thing and 'take over.' We just don't know. But it's hardly 'proven.'
First off, why do you not just 'hate' so much, but 'spite' so much? That really reflects negatively on you, not me. I've only directly insulted you once during this whole thing, while pointing out your continual BS. But that said ...
I had an extremely excellent immune response to the J&J Ad26 type, including over 2 weeks (during weeks 3-5) of pink eye-type response (even though I didn't get pink eye inflammation or membrane damage).
And it's 72% against any illness, 95% against serious illness, with the Ad26. I had none of the problems most people have with mRNA. Against the Delta variant, it seems the Ad types are building T-cells that fight it just as well.
It's hard to tell because the J&J Ad26 isn't used much outside the US, unlike the Astrazeneca which uses a different Ad attack vector.
